INM | InMed Pharmaceuticals
Latest Earnings Call / Transcript of InMed Pharmaceuticals (INM) We haven't found the most latest Earnings Call recordings yet. Stay tuned and we'll add it here as soon as we found it.
Earnings History Date EPS / Forecast Revenue / Forecast February 17, 2023 -0.91 / -4.5469.78K / 500KNovember 11, 2022 -4.06 / -4.25320.79K / 500KSeptember 23, 2022 -12.22 / -0.29514.8K / 0.97MBeat! May 13, 2022 -0.25 / -0.25309.59K / 309.59KFebruary 15, 2022 -0.31 / -0.235265.09K / 125KBeat! November 10, 2021 -0.25 / -0.35- / -September 24, 2021 -0.405 / -0.2709- / -May 20, 2021 - / -0.26- / -February 11, 2021 -0.37 / -0.1874- / -November 13, 2020 -0.34 / -0.66- / -September 8, 2020 -0.37 / -0.66- / -May 14, 2020 -0.66 / -0.02- / -February 14, 2020 -0.66 / -0.02- / -
News about InMed Pharmaceuticals earnings
Prothena, bioAffinity top healthcare gainers; Mind Medicine, Gamida lead losers' pack seekingalpha.com Sep 28, 2022 10:02 pm
InMed Pharmaceuticals GAAP EPS of -$33.17, revenue of $1.09M seekingalpha.com Sep 26, 2022 1:53 pm
InMed Pharma announces $6M private placement seekingalpha.com Sep 10, 2022 5:20 am
InMed climbs 23% amid plans to focus on pharma drug development seekingalpha.com Sep 9, 2022 7:10 pm
InMed Pharmaceuticals sinks 16% over consolidating 1 for 25 shares to meet listing requirements seekingalpha.com Aug 24, 2022 5:54 am
InMed Pharma says phase 2 trial for skin disorder cannabinol cream can now include teens seekingalpha.com Jul 25, 2022 9:01 pm
InMed names new COO seekingalpha.com Jul 18, 2022 7:35 pm
InMed Pharmaceuticals gets non-compliance notice on Nasdaq minimum bid price requirement seekingalpha.com Jul 13, 2022 3:08 pm
InMed says peer-reviewed study highlights potential role of rare cannabinoids THCV, CBC on skin conditions seekingalpha.com Jun 14, 2022 10:05 pm
InMed begins B2B sales of cannabinoid THCV seekingalpha.com Jun 9, 2022 8:56 pm
InMed Pharmaceuticals announces $5M registered direct and private placement offerings seekingalpha.com Jun 2, 2022 8:10 pm
InMed launches sale of cannabidivarin in U.S. seekingalpha.com Apr 22, 2022 12:13 am
InMed CFO steps down, interim CFO appointed seekingalpha.com Mar 17, 2022 7:57 pm
InMed Pharmaceuticals GAAP EPS of -$0.31, revenue of $0.27M seekingalpha.com Feb 15, 2022 4:06 pm
InMed launches B2B sales of rare cannabinoid cannabicitran seekingalpha.com Jan 20, 2022 1:11 am
InMed Pharma soars after releasing extracts from research report seekingalpha.com Nov 18, 2021 12:26 am
InMed Pharmaceuticals reports FQ1 results seekingalpha.com Nov 10, 2021 10:03 pm
InMed files PCT patent application for treating neurodegenerative disease seekingalpha.com Nov 3, 2021 7:51 pm
InMed shares jump 8% after completing BayMedica deal seekingalpha.com Oct 14, 2021 4:38 am
InMed Pharmaceuticals commences mid-stage INM-755 Epidermolysis Bullosa trial seekingalpha.com Sep 30, 2021 7:42 pm
InMed Pharmaceuticals reports FY results seekingalpha.com Sep 24, 2021 7:36 pm
InMed Pharmaceuticals to acquire BayMedica for 1.78M InMed shares seekingalpha.com Sep 14, 2021 1:05 am
InMed Pharma signs LOI to acquire rare cannabinoids manufacturer BayMedica seekingalpha.com Jun 29, 2021 7:42 pm
InMed Pharma shares climb on launch of $12M private placement seekingalpha.com Jun 29, 2021 7:31 pm
InMed Pharmaceuticals reports FQ3 results seekingalpha.com May 13, 2021 7:34 pm
InMed Pharma files applications to evaluate INM-755 for epidermolysis bullosa seekingalpha.com Apr 28, 2021 8:45 pm
InMed Pharmaceuticals reports Q4 results seekingalpha.com Feb 11, 2021 8:42 pm
InMed to raise $4.5M in private placement seekingalpha.com Feb 5, 2021 10:44 pm
InMed's INM-755 CBN cream did not introduce any delay in normal wound healing seekingalpha.com Jan 8, 2021 9:27 pm
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
investors.inmedpharma.com If you are looking for News & events, Press Release, they are available on their Investors Relations site.
If you want to help pay for server cost or for improving this tool. You can send it via Paypal . More features coming soon :)
Buy on Amazon Very few careers can offer you the freedom, flexibility, and income that day trading does. As a day trader, you can live and work anywhere in the world. You can decide when to work and when not to work. You only answer to yourself. That is the life of the successful day trader. Many people aspire to it, but very few succeed.
A Beginner's Guide to Trading Tools and Tactics, Money Management, Discipline and Trading Psychology